In a Wall Street Journal opinion piece, James Mullen, CEO of Biogen Idec and chairman of BIO, recounts the successes of the biotech industry while warning that "a witch's brew of initiatives" currently proposed by US lawmakers could have a serious impact on the field.
Since Mullen's article was published, a number of people have responded through the WSJ blog. You can check out that running discussion here.
Â